Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice
✍ Scribed by S.M. Biswas; S. Kar; R. Singh; D. Chakraborty; V. Vipat; C.G. Raut; A.C. Mishra; M.M. Gore; D. Ghosh
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 252 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Japanese encephalitis virus (JEV) induces an acute infection of the central nervous system, the pathogenic mechanism of which is not fully understood. To investigate host response to JEV infection, 14‐day‐old mice were infected via the extraneural route, which resulted in encephalitis and death. Mice that received JEV immune splenocyte transfer were protected from extraneural JEV infection. Pathology and gene expression profiles were then compared in brains of mice that either succumbed to JEV infection or were protected from infection by JEV immune cell transfer. Mice undergoing progressive JEV infection had increased expression of proinflammatory cytokines, chemokines, and signal transducers associated with the interferon (IFN) pathway. In contrast, mice receiving immune cell transfer had increased production of the Th2 cytokine IL‐4, and of IL‐10, with subdued expression of IFN‐γ. We observed IL‐10 to be an important factor in determining clinical outcome in JEV infection. Data obtained by microarray analysis were further confirmed by quantitative RT‐PCR. Together, these data suggest that JEV infection causes an unregulated inflammatory response that can be countered by the expression of immunomodulatory cytokines in mice that survive lethal infection. J. Med. Virol. 82:304–310, 2010. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The reasons for the different outcome of coxsackievirus B3 (CVB3)‐induced heart disease in humans are not well understood. Since there are no experimental data on the course of disease after infection with genetically different CVB3 in a natural variable population until now, we studied
## Abstract RSV is an important cause of bronchiolitis in infants. Immunopathology may play a role in RSV‐induced bronchiolitis and severe RSV‐induced disease has been associated with a Th2 type immune response. The aim of the study was to identify cytokine pathways that are crucial in influencing
biochemical and histological improvement. 3,4 Several factors Hepatitis C virus (HCV) genotype 1b and high precan predict a poor response to interferon therapy, e.g., high treatment virus load are predictive factors of poor repretreatment virus load, genotype 1b, advanced histological sponse to inte